MannKind (MNKD) Completes Acquisition of Insulin Assets from Pfizer (PFE)
Tweet Send to a Friend
MannKind Corporation (Nasdaq: MNKD) has completed its acquisition from Pfizer Inc. (NYSE: PFE) of a quantity of bulk insulin and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
